
Keywords: ACEi; angiotensin-converting enzyme inhibitor; AE; adverse event; AKI; acute kidney injury; AngII; angiotensin II; ARB; angiotensin receptor blocker; AT1; angiotensin receptor type 1; AT2; angiotensin receptor type 2; BMI; body mass index; CVA; cerebrovas